JPS57167921A - Manufacture of epithelial formation composition - Google Patents

Manufacture of epithelial formation composition

Info

Publication number
JPS57167921A
JPS57167921A JP57042480A JP4248082A JPS57167921A JP S57167921 A JPS57167921 A JP S57167921A JP 57042480 A JP57042480 A JP 57042480A JP 4248082 A JP4248082 A JP 4248082A JP S57167921 A JPS57167921 A JP S57167921A
Authority
JP
Japan
Prior art keywords
manufacture
formation composition
treatment
injuries
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57042480A
Other languages
English (en)
Other versions
JPH0354086B2 (ja
Inventor
Emilia Szijjarto
Magda Raskai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Oltoanyagtermelo Es Kutato Intezet
Original Assignee
Human Oltoanyagtermelo Es Kutato Intezet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo Es Kutato Intezet filed Critical Human Oltoanyagtermelo Es Kutato Intezet
Publication of JPS57167921A publication Critical patent/JPS57167921A/ja
Publication of JPH0354086B2 publication Critical patent/JPH0354086B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S2/00—Apparel
    • Y10S2/908—Guard or protector having a hook-loop type fastener
    • Y10S2/91—Hand or wrist protector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
JP57042480A 1981-03-17 1982-03-17 Manufacture of epithelial formation composition Granted JPS57167921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU81663A HU195618B (en) 1981-03-17 1981-03-17 Process for producing composition for treating epidermic lesions of skin

Publications (2)

Publication Number Publication Date
JPS57167921A true JPS57167921A (en) 1982-10-16
JPH0354086B2 JPH0354086B2 (ja) 1991-08-19

Family

ID=10950733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57042480A Granted JPS57167921A (en) 1981-03-17 1982-03-17 Manufacture of epithelial formation composition

Country Status (7)

Country Link
US (2) US4466961A (ja)
EP (1) EP0060553B1 (ja)
JP (1) JPS57167921A (ja)
AT (1) ATE17079T1 (ja)
DE (1) DE3268075D1 (ja)
HU (1) HU195618B (ja)
IL (1) IL65201A (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246332A (ja) * 1997-12-19 1999-09-14 L'oreal Sa 化粧料におけるケイ皮酸またはその誘導体の用途
JPH11246333A (ja) * 1997-12-19 1999-09-14 L'oreal Sa 収斂用化粧料におけるケイ皮酸またはその誘導体の用途
JPH11246328A (ja) * 1997-12-19 1999-09-14 L'oreal Sa 化粧料におけるフロログルシノールの用途
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
US6660283B2 (en) 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE59298T1 (de) * 1982-09-17 1991-01-15 Human Oltoanyagtermelo Praeparate zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung derartiger praeparate.
US4889844A (en) * 1985-10-22 1989-12-26 Silvetti Sr Anthony N Fructose containing wound healing preparation
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
HU200103B (en) * 1987-04-01 1990-04-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for treating lack of epithelium
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
US5466680A (en) * 1992-03-26 1995-11-14 Cytologics, Inc. Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
IT1255029B (it) * 1992-05-11 1995-10-13 Paolo Morazzoni Formulazioni farmaceutiche orali contenenti antocianosidi
EP0673236A4 (en) * 1992-12-10 1999-07-07 Hemogen Inc METHOD FOR STIMULATING THE PRODUCTION OF HEM OXYGENASE USING VITAMIN B12.
US5498603A (en) * 1993-07-07 1996-03-12 Clodman; Percy B. Method for the stimulation of hair growth
US5420114A (en) * 1993-07-07 1995-05-30 Clodman; Percy B. Methods for the treatment of skin disorders
WO1996022081A1 (en) * 1995-01-17 1996-07-25 Omega Pharmaceutical, Incorporated Liquid stable vitamin c compositions and delivery systems, and methods of making and uses thereof
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
FR2772611B1 (fr) * 1997-12-19 2003-08-15 Oreal Utilisation d'au moins une auxine dans une composition cosmetique raffermissante
FR2772609B1 (fr) * 1997-12-19 2004-05-07 Oreal Utilisation d'au moins une auxine dans une composition cosmetique
AU1041400A (en) * 1998-10-23 2000-05-15 Dieter Ebert Composition containing eugenol and polyphenols and use of such a composition forwound healing
FR2809003B1 (fr) * 2000-05-18 2003-01-24 Oreal Compositions anti-pollution a base d'anthocyanes
HU0104790D0 (en) * 2001-11-08 2002-01-28 Human Rt Pharmaceutical combinations for topical application
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
US20050152996A1 (en) * 2003-12-01 2005-07-14 BUTLER Donald Extracts of Mimulus aurantiacus for treating psoriasis and repelling insects
GB0505909D0 (en) * 2005-03-23 2005-04-27 Univ Leeds Formulations
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
WO2007089267A1 (en) 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7687650B2 (en) * 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
JP2009532020A (ja) * 2006-03-03 2009-09-10 セ・イ・エ・エメ・ア・テ 紫外線に過敏な移植されたヒト皮膚を含むマウスモデル
US20070264222A1 (en) * 2006-05-10 2007-11-15 Biohealth Advance, Llc Enhanced protection against skin injury in humans
WO2007136858A2 (en) 2006-05-19 2007-11-29 H. Lee Moffitt Cancer Center & Research Institute Small molecule inhibitors of stat3 with anti-tumor activity
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
TWI331033B (en) * 2007-04-26 2010-10-01 Yangsen Biotechnology Co Ltd Composition for inhibiting no and/or prostaglandin e2 synthesis and uses thereof
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110008271A1 (en) * 2009-07-13 2011-01-13 Jr Chem, Llc Rosacea treatments using polymetal complexes
DE102009052808A1 (de) * 2009-11-13 2011-05-26 Roman Hasenkopf Eine Heilsalbe mit mindestens einem homöopathisch verdünnten Mineralsalz
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
JP5964670B2 (ja) * 2012-06-21 2016-08-03 ピアス株式会社 骨髄間葉系幹細胞の誘引剤、骨髄間葉系幹細胞の誘引方法、及び、骨髄間葉系幹細胞の誘引剤を製造するためのシンナムタンニンｂ１の使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791181A (fr) * 1971-11-15 1973-03-01 Halliez Bernard Composition a base de tanin a l'acetate d'ethyle
US3833732A (en) * 1973-05-24 1974-09-03 Miles Lab Method of treating inflammation utilizing alkyl esters of gallic acid
US3943248A (en) * 1974-11-04 1976-03-09 Shulman Max J Methods of treating burns using colophony containing preparations
US4235889A (en) * 1979-04-25 1980-11-25 Pharmazeutische Fabrik Evers & Co. Therapeutic agent for the external treatment of psoriasis, tinea and eczemas

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246332A (ja) * 1997-12-19 1999-09-14 L'oreal Sa 化粧料におけるケイ皮酸またはその誘導体の用途
JPH11246333A (ja) * 1997-12-19 1999-09-14 L'oreal Sa 収斂用化粧料におけるケイ皮酸またはその誘導体の用途
JPH11246328A (ja) * 1997-12-19 1999-09-14 L'oreal Sa 化粧料におけるフロログルシノールの用途
US6054137A (en) * 1997-12-19 2000-04-25 Societe L'oreal S.A. Promoting epidermal renewal with phloroglucinol
US6264962B1 (en) 1997-12-19 2001-07-24 Societe L'oreal S.A. Use of cinnamic acid or of at least one of its derivatives in a cosmetic composition
US6267971B1 (en) 1997-12-19 2001-07-31 Societe L'oreal S.A. Use of cinnamic acid or of its derivatives in a cosmetic firming composition
US6660283B2 (en) 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料

Also Published As

Publication number Publication date
JPH0354086B2 (ja) 1991-08-19
DE3268075D1 (en) 1986-02-06
IL65201A (en) 1986-01-31
US4466961A (en) 1984-08-21
ATE17079T1 (de) 1986-01-15
US4503037A (en) 1985-03-05
EP0060553B1 (de) 1985-12-27
EP0060553A1 (de) 1982-09-22
HU195618B (en) 1988-06-28
IL65201A0 (en) 1982-05-31

Similar Documents

Publication Publication Date Title
JPS57167921A (en) Manufacture of epithelial formation composition
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
PT92069A (pt) Processo para a producao de um sistema de distribuicao de drogas
HUT54891A (en) Process for producing pharmaceutical compositions against lesions destroying nerve tissue
FI935847A (fi) L-DOPA-esterikoostumukset
PT76502B (en) Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences
EP0403048A3 (en) Medicated compositions containing sucralfate and processes for their production
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
JPS57197221A (en) Novel antithrombotic comprising mixture of oligosaccharides and polysaccharides, manufacture and medicinal composition
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
BE890808A (fr) Nouvelle forme galenique d'administration de metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
ES536055A0 (es) Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii
BE900012A (fr) Nouveau peptide.
JPS6468320A (en) Remedy for psychotic disease or like and therapeutical solution
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
OA09121A (fr) Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.
BE899612A (fr) Derives 1 alpha, 25-dihydroxiles de la vitamine d2 et produits intermediaires pour leur preparation et compositions pharmaceutiques renfermant ces derives.
EG17992A (en) Preparation of a medicament for arthritis and theumatism
BE878256A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
DE2963730D1 (en) 1,4-dihydropyridazine-3-carbonyl compounds, process for their preparation, the compounds for use in curing diseases, medicaments containing them and process for the preparation of the medicaments
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
Balunov et al. The experience in the use of piracetam in patients with consequences of stroke.